Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling.
Moslin, R., Gardner, D., Santella, J., Zhang, Y., Duncia, J.V., Liu, C., Lin, J., Tokarski, J.S., Strnad, J., Pedicord, D., Chen, J., Blat, Y., Zupa-Fernandez, A., Cheng, L., Sun, H., Chaudhry, C., Huang, C., D'Arienzo, C., Sack, J.S., Muckelbauer, J.K., Chang, C., Tredup, J., Xie, D., Aranibar, N., Burke, J.R., Carter, P.H., Weinstein, D.S.(2017) Medchemcomm 8: 700-712
- PubMed: 30108788 
- DOI: 10.1039/c6md00560h
- Primary Citation of Related Structures:  
5TKB, 5TKD - PubMed Abstract: 
As a member of the Janus (JAK) family of non-receptor tyrosine kinases, TYK2 mediates the signaling of pro-inflammatory cytokines including IL-12, IL-23 and type 1 interferon (IFN), and therefore represents an attractive potential target for treating the various immuno-inflammatory diseases in which these cytokines have been shown to play a role ...